Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up.
Related Posts
Gucci’s Owner Lost His Patience. What Came Next Was a Grand Reinvention.
French billionaire François-Henri Pinault is taking hands-on approach as he scrambles to catch up to rival LVMH.
How a Leak by a New York Times Reporter Led to an Anti-Doxing Uproar in Australia
Members of a WhatsApp group for Jewish professionals were harassed after their chat thread fell into the hands of pro-Palestinian activists.
CVC Confident After Key Metric Beat
CVC Capital Partners reported better-than-expected management fee earnings for the first half of the year and said it was confident on its outlook.